Cargando…

Advances of Mechanisms-Related Metabolomics in Parkinson’s Disease

Parkinson’s disease (PD) is a multifactorial disorder characterized by progressively debilitating dopaminergic neurodegeneration in the substantia nigra and the striatum, along with various metabolic dysfunctions and molecular abnormalities. Metabolomics is an emerging study and has been demonstrate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Yanyan, Li, Jie, Zhang, Xiao, Song, Dongdong, Tian, Tian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887307/ https://www.ncbi.nlm.nih.gov/pubmed/33613180 http://dx.doi.org/10.3389/fnins.2021.614251

Ejemplares similares

Retinal Degeneration: A Window to Understand the Origin and Progression of Parkinson’s Disease?
por: Zhang, Yanyan, et al.
Publicado: (2022)

Dysfunction of Synaptic Vesicle Endocytosis in Parkinson’s Disease
por: Zou, Li, et al.
Publicado: (2021)

The Mechanism and Function of Glia in Parkinson's Disease
por: Zhang, Xinguo, et al.
Publicado: (2022)

Editorial: Genetic and Epigenetic Mechanisms of Parkinson's Disease
por: Li, Song, et al.
Publicado: (2022)

Integrated Metabolomics and Proteomics Analysis Reveals Plasma Lipid Metabolic Disturbance in Patients With Parkinson’s Disease
por: Hu, Ling, et al.
Publicado: (2020)

Mitophagy in Parkinson’s Disease: Pathogenic and Therapeutic Implications
por: Gao, Fei, et al.
Publicado: (2017)

Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson’s Disease
por: Yang, Zhengjie, et al.
Publicado: (2021)

Recent Advances in Biomarkers for Parkinson’s Disease
por: He, Runcheng, et al.
Publicado: (2018)

Alterations of the Motor and Olfactory Functions Related to Parkinson’s Disease in Transgenic Mice With a VMAT2-Deficiency in Dopaminergic Neurons
por: Jiang, Song, et al.
Publicado: (2020)

Novel diagnostic biomarkers related to immune infiltration in Parkinson’s disease by bioinformatics analysis
por: Zhang, Pengfei, et al.
Publicado: (2023)

Integrative Metabolomic and Metallomic Analysis in a Case–Control Cohort With Parkinson’s Disease
por: Lucio, Marianna, et al.
Publicado: (2019)

Corrigendum: High levels of Bifidobacteriaceae are associated with the pathogenesis of Parkinson's disease
por: Zuo, ShuJia, et al.
Publicado: (2023)

Longitudinal Analysis of Fecal Microbiome and Pathologic Processes in a Rotenone Induced Mice Model of Parkinson’s Disease
por: Yang, Xiaodong, et al.
Publicado: (2018)

Prion-Like Mechanisms in Parkinson’s Disease
por: Ma, Jiangnan, et al.
Publicado: (2019)

Diagnostic value of striatal (18)F-FP-DTBZ PET in Parkinson’s disease
por: Liu, Xiu-Lin, et al.
Publicado: (2022)

Insights Into the Role of Platelet-Derived Growth Factors: Implications for Parkinson’s Disease Pathogenesis and Treatment
por: Li, Dan, et al.
Publicado: (2022)

Abnormal brain activities in multiple frequency bands in Parkinson’s disease with apathy
por: Xu, Haikun, et al.
Publicado: (2022)

The Bulbocavernosus Reflex in the Differential Diagnosis of Multiple System Atrophy with Predominant Parkinsonism and Parkinson’s Disease
por: Huang, Huan-jie, et al.
Publicado: (2018)

Mechanisms of Body Weight Fluctuations in Parkinson’s Disease
por: Kistner, Andrea, et al.
Publicado: (2014)

Molecular Mechanisms of Glutamate Toxicity in Parkinson’s Disease
por: Wang, Ji, et al.
Publicado: (2020)

The mechanism of exercise for pain management in Parkinson’s disease
por: Yu, Wen-Ye, et al.
Publicado: (2022)

High levels of Bifidobacteriaceae are associated with the pathogenesis of Parkinson’s disease
por: Zuo, ShuJia, et al.
Publicado: (2023)

LMNB1-Related Adult-Onset Autosomal Dominant Leukodystrophy Presenting as Movement Disorder: A Case Report and Review of the Literature
por: Zhang, Yanyan, et al.
Publicado: (2019)

Effect of Dopaminergic Medication on Postural Sway in Advanced Parkinson’s Disease
por: Revilla, Fredy J., et al.
Publicado: (2013)

The Ventral Intermediate Nucleus Differently Modulates Subtype-Related Networks in Parkinson’s Disease
por: Zeng, Qiaoling, et al.
Publicado: (2019)

Alpha-Synuclein Induced Immune Cells Activation and Associated Therapy in Parkinson’s Disease
por: Su, Ruichen, et al.
Publicado: (2021)

Serum metabolomics analysis revealed metabolic disorders in Parkinson’s disease
por: Lan, Tian-Tian, et al.
Publicado: (2023)

Integrative analysis of DNA methylation and gene expression data for the diagnosis and underlying mechanism of Parkinson’s disease
por: Li, Ding, et al.
Publicado: (2022)

Nigral Iron Deposition Is Associated With Levodopa-Induced Dyskinesia in Parkinson’s Disease
por: Song, Tianbin, et al.
Publicado: (2021)

Pathological Mechanisms Linking Diabetes Mellitus and Alzheimer’s Disease: the Receptor for Advanced Glycation End Products (RAGE)
por: Kong, Yanyan, et al.
Publicado: (2020)

Severity-dependent functional connectome and the association with glucose metabolism in the sensorimotor cortex of Parkinson's disease
por: Zang, Zhenxiang, et al.
Publicado: (2023)

Mechanisms of α-Synuclein Induced Synaptopathy in Parkinson's Disease
por: Bridi, Jessika C., et al.
Publicado: (2018)

Caffeine and Parkinson’s Disease: Multiple Benefits and Emerging Mechanisms
por: Ren, Xiangpeng, et al.
Publicado: (2020)

Levodopa-Induced Changes in Electromyographic Patterns in Patients with Advanced Parkinson’s Disease
por: Ruonala, Verneri, et al.
Publicado: (2018)

Management of advanced Parkinson’s disease in Israel: Clinicians viewpoint and action items
por: Gurevich, Tanya, et al.
Publicado: (2022)

Recent advances and perspectives of metabolomics-based investigations in Parkinson’s disease
por: Shao, Yaping, et al.
Publicado: (2019)

Update to the Treatment of Parkinson’s Disease Based on the Gut-Brain Axis Mechanism
por: Sun, Xiaohui, et al.
Publicado: (2022)

Different mechanisms contributing to savings and anterograde interference are impaired in Parkinson's disease
por: Leow, Li-Ann, et al.
Publicado: (2013)

Emerging Role of Sirtuin 2 in Parkinson’s Disease
por: Liu, Yumei, et al.
Publicado: (2020)

Longitudinal Macro/Microstructural Alterations of Different Callosal Subsections in Parkinson’s Disease Using Connectivity-Based Parcellation
por: Wu, Jingjing, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qqdql2m0eo189p1hag6kvv3vuc